scholarly article | Q13442814 |
P356 | DOI | 10.1007/978-3-319-51436-9_12 |
P698 | PubMed publication ID | 28409351 |
P2093 | author name string | Bradley K Yoder | |
Kurt A Zimmerman | |||
Cheng Jack Song | |||
Scott J Henke | |||
P2860 | cites work | Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis | Q24649584 |
Cilia in vertebrate development and disease | Q26829114 | ||
The renal mononuclear phagocytic system | Q27024367 | ||
Transmembrane crosstalk between the extracellular matrix--cytoskeleton crosstalk | Q28206345 | ||
Ras and relatives--job sharing and networking keep an old family together | Q28207903 | ||
PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2 | Q28585618 | ||
A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease | Q28588616 | ||
Monocyte and macrophage heterogeneity | Q29547438 | ||
Macrophage plasticity and polarization: in vivo veritas | Q29547620 | ||
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes | Q29547633 | ||
Activators and target genes of Rel/NF-kappaB transcription factors | Q29547882 | ||
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF | Q29615685 | ||
The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia | Q29615732 | ||
Fate mapping analysis reveals that adult microglia derive from primitive macrophages | Q29616177 | ||
A lineage of myeloid cells independent of Myb and hematopoietic stem cells | Q29620147 | ||
Macrophage biology in development, homeostasis and disease | Q29620350 | ||
A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation | Q30432740 | ||
The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury | Q30439547 | ||
A possible role for metalloproteinases in renal cyst development | Q31956102 | ||
Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis | Q33556248 | ||
Macrophages promote polycystic kidney disease progression | Q33640257 | ||
Origin and function of myofibroblasts in kidney fibrosis | Q33792700 | ||
Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1). | Q33894724 | ||
The cleaved cytoplasmic tail of polycystin-1 regulates Src-dependent STAT3 activation | Q33974670 | ||
Clinical practice. Autosomal dominant polycystic kidney disease | Q34013969 | ||
Macrophages: master regulators of inflammation and fibrosis | Q34076279 | ||
Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis | Q34399827 | ||
Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks | Q34658323 | ||
Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. | Q34659689 | ||
A hypomorphic mutation in the mouse laminin alpha5 gene causes polycystic kidney disease | Q34696383 | ||
Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases | Q34769315 | ||
Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease | Q34982718 | ||
Renal F4/80+ CD11c+ mononuclear phagocytes display phenotypic and functional characteristics of macrophages in health and in adriamycin nephropathy | Q35027269 | ||
Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia. | Q35148415 | ||
Urinary Excretion of Monocyte Chemoattractant Protein-1 in Autosomal Dominant Polycystic Kidney Disease | Q44599924 | ||
Chymase-like angiotensin II-generating activity in end-stage human autosomal dominant polycystic kidney disease | Q44745236 | ||
Abnormal extracellular matrix and excessive growth of human adult polycystic kidney disease epithelia | Q45164388 | ||
KCa3.1 potassium channels are critical for cAMP-dependent chloride secretion and cyst growth in autosomal-dominant polycystic kidney disease | Q46544739 | ||
Characterisation and trophic functions of murine embryonic macrophages based upon the use of a Csf1r-EGFP transgene reporter | Q48123453 | ||
Serine proteases, inhibitors and receptors in renal fibrosis. | Q50357092 | ||
Dual role of CCR2 during initiation and progression of collagen-induced arthritis: evidence for regulatory activity of CCR2+ T cells. | Q51830522 | ||
Activin disrupts epithelial branching morphogenesis in developing glandular organs of the mouse. | Q52508721 | ||
Insertional mutagenesis and molecular analysis of a new gene associated with polycystic kidney disease. | Q52519174 | ||
Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. | Q53363185 | ||
Gene profiling of polycystic kidneys. | Q53633652 | ||
Effects of MCP-1 inhibition by bindarit therapy in a rat model of polycystic kidney disease. | Q53662242 | ||
Increased apoptosis and proliferative capacity are early events in cyst formation in autosomal-dominant, polycystic kidney disease. | Q55026976 | ||
Temporal Relationship between Renal Cyst Development, Hypertension and Cardiac Hypertrophy in a New Rat Model of Autosomal Recessive Polycystic Kidney Disease | Q60728045 | ||
Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats | Q62393763 | ||
Treatment targets in renal fibrosis | Q62805964 | ||
Renal histology in polycystic kidney disease with incipient and advanced renal failure | Q67595264 | ||
A hereditary model of slowly progressive polycystic kidney disease in the mouse | Q67962191 | ||
Hereditary polycystic kidney disease associated with osteorenal syndrome in rats | Q69687808 | ||
Autosomal-dominant polycystic kidney disease in the rat | Q70616833 | ||
Tubular gelatinase A (MMP-2) and its tissue inhibitors in polycystic kidney disease in the Han:SPRD rat | Q71437952 | ||
Matrix metalloproteinases and TIMPS in cultured C57BL/6J-cpk kidney tubules | Q71690228 | ||
Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD | Q72005760 | ||
Increased endothelin and endothelin receptor mRNA expression in polycystic kidneys of cpk mice | Q72664227 | ||
The PKD1 gene product, "polycystin-1," is a tyrosine-phosphorylated protein that colocalizes with alpha2beta1-integrin in focal clusters in adherent renal epithelia | Q73110187 | ||
Clinical and pathologic findings in two new allelic murine models of polycystic kidney disease | Q73253314 | ||
Elevation of serum levels of metalloproteinase-1, tissue inhibitor of metalloproteinase-1 and type IV collagen, and plasma levels of metalloproteinase-9 in polycystic kidney disease | Q73378459 | ||
Acidic FGF regulation of hyperproliferation of fibroblasts in human autosomal dominant polycystic kidney disease | Q73593466 | ||
Polycystic kidney disease in bull terriers: an autosomal dominant inherited disorder | Q73795458 | ||
A novel inhibitor of tumor necrosis factor-alpha converting enzyme ameliorates polycystic kidney disease | Q74566799 | ||
Polycystic kidney disease | Q75230730 | ||
Cystic diseases of the kidney: role of adhesion molecules in normal and abnormal tubulogenesis | Q77358323 | ||
A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal-dominant polycystic kidney disease | Q80707010 | ||
Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin | Q80803975 | ||
Adoptive transfer of macrophages ameliorates renal fibrosis in mice | Q81751218 | ||
Epithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous PCK rat model of autosomal-recessive polycystic kidney disease | Q82488439 | ||
Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease | Q84409384 | ||
Effects of specific genes activating RAGE on polycystic kidney disease | Q84532473 | ||
Mechanisms of tubulointerstitial fibrosis | Q85074102 | ||
Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD). | Q35194509 | ||
Inactivation of integrin-β1 prevents the development of polycystic kidney disease after the loss of polycystin-1. | Q35228509 | ||
Murine models of polycystic kidney disease: molecular and therapeutic insights | Q35576595 | ||
Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. | Q35623089 | ||
Involvement of hypoxia-inducible transcription factors in polycystic kidney disease | Q35781329 | ||
Regulation of PDGF and its receptors in fibrotic diseases | Q35811100 | ||
Focal adhesion regulation of cell behavior. | Q35832734 | ||
Beta4 integrin and laminin 5 are aberrantly expressed in polycystic kidney disease: role in increased cell adhesion and migration | Q35843445 | ||
Heme Oxygenase-1 Regulates Myeloid Cell Trafficking in AKI | Q36003153 | ||
c-Met and NF-κB-dependent overexpression of Wnt7a and -7b and Pax2 promotes cystogenesis in polycystic kidney disease | Q36109160 | ||
Disruption of intraflagellar transport in adult mice leads to obesity and slow-onset cystic kidney disease | Q36156370 | ||
STAT3 Signaling in Polycystic Kidney Disease | Q36218762 | ||
The origin and kinetics of mononuclear phagocytes | Q36269269 | ||
The renal cortical fibroblast in renal tubulointerstitial fibrosis | Q36288501 | ||
Tubulocystic epithelium | Q36397804 | ||
Langerhans cells renew in the skin throughout life under steady-state conditions | Q36505129 | ||
A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1 | Q36549183 | ||
Proximal tubule proliferation is insufficient to induce rapid cyst formation after cilia disruption | Q36638342 | ||
Role of matrix metalloproteinases in renal pathophysiologies | Q36693229 | ||
Role of primary cilia in the pathogenesis of polycystic kidney disease | Q36788907 | ||
Trophic macrophages in development and disease | Q36829147 | ||
BMP7 null mutation in mice: developmental defects in skeleton, kidney, and eye. | Q36844287 | ||
Cystic disease of the kidney. | Q37014727 | ||
Exclusive CX3CR1 dependence of kidney DCs impacts glomerulonephritis progression | Q37200899 | ||
Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics | Q37218669 | ||
Renal injury is a third hit promoting rapid development of adult polycystic kidney disease | Q37239858 | ||
Macrophage polarization in bacterial infections | Q37259940 | ||
Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels | Q37305118 | ||
Pkd2 dosage influences cellular repair responses following ischemia-reperfusion injury | Q37362069 | ||
Mouse models of polycystic kidney disease | Q37383079 | ||
A Pkd1-Fbn1 genetic interaction implicates TGF-β signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney disease. | Q37411615 | ||
Emerging therapies for chronic kidney disease: what is their role? | Q37489497 | ||
Biology of mast cell tryptase and chymase | Q37519021 | ||
Endothelial primary cilia inhibit atherosclerosis. | Q37623301 | ||
Periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease | Q37678557 | ||
Transcriptomic analyses of murine resolution-phase macrophages | Q37716039 | ||
Regulation of myofibroblast activities: calcium pulls some strings behind the scene | Q37745598 | ||
Macrophages and renal fibrosis | Q37771627 | ||
Why kidneys fail in autosomal dominant polycystic kidney disease | Q37921597 | ||
The ciliary flow sensor and polycystic kidney disease | Q38073602 | ||
Role of interstitial inflammation in the pathogenesis of polycystic kidney disease | Q38085407 | ||
Macrophage-mediated injury and repair after ischemic kidney injury. | Q38180032 | ||
Monocytes and macrophages: developmental pathways and tissue homeostasis | Q38214042 | ||
SnapShot: Sensing and Signaling by Cilia | Q38538452 | ||
Macrophages promote cyst growth in polycystic kidney disease | Q38628997 | ||
TNF Counterbalances the Emergence of M2 Tumor Macrophages | Q38835677 | ||
The primary cilium influences interleukin-1β-induced NFκB signalling by regulating IKK activity. | Q39004852 | ||
Inhibition of Activin Signaling Slows Progression of Polycystic Kidney Disease. | Q39884248 | ||
The Cell Biology of Macrophage Activation | Q40081110 | ||
The ADPKD genes pkd1a/b and pkd2 regulate extracellular matrix formation | Q40236123 | ||
Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease | Q40332825 | ||
The pathology of human renal cystic disease. | Q40447184 | ||
Activin A is a potent activator of renal interstitial fibroblasts | Q40604314 | ||
New insights into the multidimensional concept of macrophage ontogeny, activation and function. | Q40866271 | ||
Functional aspects of primary cilia in signaling, cell cycle and tumorigenesis | Q40963789 | ||
Differential Ly6C Expression after Renal Ischemia-Reperfusion Identifies Unique Macrophage Populations | Q41472438 | ||
Cytokines in fluids from polycystic kidneys | Q41772239 | ||
Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease | Q41891142 | ||
Primary cilia elongation in response to interleukin-1 mediates the inflammatory response. | Q42272239 | ||
Overexpression of innate immune response genes in a model of recessive polycystic kidney disease | Q42520740 | ||
Pkd1 haploinsufficiency increases renal damage and induces microcyst formation following ischemia/reperfusion | Q42946110 | ||
Elevated SMAD1/beta-catenin molecular complexes and renal medullary cystic dysplasia in ALK3 transgenic mice | Q44433263 | ||
Activin a produced by ureteric bud is a differentiation factor for metanephric mesenchyme | Q44449835 | ||
Epidermal Langerhans cells are derived from cells originating in bone marrow | Q44522186 | ||
P304 | page(s) | 323-344 | |
P577 | publication date | 2017-01-01 | |
P1433 | published in | Results and problems in cell differentiation | Q26842363 |
P1476 | title | Inflammation and Fibrosis in Polycystic Kidney Disease | |
P478 | volume | 60 |
Q55415494 | Celastrol alleviates renal fibrosis by upregulating cannabinoid receptor 2 expression. |
Q91639633 | Four-jointed knock-out delays renal failure in an ADPKD model with kidney injury |
Q88738703 | GLIS1-3 transcription factors: critical roles in the regulation of multiple physiological processes and diseases |
Q94519328 | Polycystic kidney disease |
Q90081479 | TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes |
Q52310160 | Three dimensional in vitro models answer the right questions in ADPKD cystogenesis. |
Search more.